BOILLHEALTHCARE (01246) announced its interim performance, with a net loss attributable to owners of the company of HK$35.09 million, an increase of 31.65% year-on-year.

Boill Healthcare (01246) announced its interim results for the six-month period ending September 30, 2025, with a profit of HK$51.738 million, representing a year-on-year increase of approximately 59%. The company's attributable loss was HK$35.509 million, an increase of 31.65% compared to the same period last year, resulting in a loss per share of HK$0.261. According to the announcement, the increase in profit was mainly due to higher sales in the building materials and health, medical, and leisure segments, as well as a decrease in net impact from property delivered under the Yangzhong project in the six months ending September 30, 2024. The increase in net loss was primarily caused by a decrease in gross profit and an increase in financial costs.